Results 181 to 190 of about 12,138 (221)

Anticardiolipin antibodies in ectopic pregnancies

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2001
Anticardiolipin auto-antibodies are known to be inflicted in recurrent pregnancy losses and other adverse outcomes of pregnancy. However, their role in extrauterine pregnancies is unknown.To clarify the association between anticardiolipin antibodies and extrauterine pregnancies.About 30 patients with ectopic pregnancies confirmed histologically and 40 ...
M, Jacob-Meisel, T, Römer, W, Straube, P, Meisel   +3 more
openaire   +2 more sources

Anticardiolipin Antibodies in Behçet's Disease

The Journal of Dermatology, 1990
AbstractTwenty‐six patients with Behçet's disease were studied for serum levels of anticardiolipin (ACL) antibody isotypes IgG and IgM. The frequency of elevated levels of ACL antibody isotype IgM was found to be significantly increased in these patients.
R, Bergman, M, Lorber, M, Lerner, R, Brik, R, Friedman-Birnbaum   +4 more
openaire   +2 more sources

Anticardiolipin antibodies in hemodialysis patients

Transplantation Proceedings, 1999
END-STAGE renal disease (ESRD) patients are known to have a higher frequency of elevated anticardiolipin antibodies (aCL) compared with the general population. The prevalence of elevated aCL in hemodialysis (HD) patients exceeds that of ESRD patients who are on conservative treatment.
N, Ozdemir, G, Güz, S, Sezer, A, Haberal, H, Ayaz, M, Haberal   +5 more
openaire   +2 more sources

Anticardiolipin antibodies A review of the literature

Journal of Nurse-Midwifery, 1994
Repeated fetal loss may be a result of a variety of causes. Immunological factors have been implicated in fetal loss, intrauterine growth retardation, preeclampsia, and thrombocytopenia. Anticardiolipin antibodies (ACAs) belong to a family of autoantibodies known as antiphospholipid antibodies.
openaire   +2 more sources

Functional Effects of Anticardiolipin Antibodies

Lupus, 1996
The ‘lupus anticoagulant’ phenomenon is the best documented functional effect of antiphospholipid (aPL) antibodies, occurring either by inhibition of the prothrombinase and/or Factor X activation reactions. Understanding the mechanism by which aPL antibodies inhibit phospholipid dependent coagulation reactions may yield important ...
E N, Harris, S S, Pierangeli
openaire   +2 more sources

Buerger's disease and anticardiolipin antibodies

Journal of Cardiovascular Medicine, 2009
Thromboangiitis obliterans or Buerger's disease is an occlusive, inflammatory, nonatherosclerotic vascular disease of unknown etiology, which affects mainly the small and medium arteries, veins and nerves. Anticardiolipin antibodies are associated with arterial and venous thrombosis, repetitive miscarriages and thrombocytopenia.
José Maria, Pereira de Godoy, Domingo Marcolino, Braile   +1 more
openaire   +2 more sources

ANTICARDIOLIPIN ANTIBODIES IN RHEUMATOID ARTHRITIS

Rheumatology, 1987
Anticardiolipin antibody (ACA) was present in the sera of 49% of 90 consecutive patients with rheumatoid arthritis (RA). The ACA was absent in 30 control patients with osteoarthritis. C-reactive protein levels equal to or exceeding 7 mg/dl were found in 10 patients all of whom were ACA positive.
A, Keane, R, Woods, V, Dowding, D, Roden, C, Barry   +4 more
openaire   +2 more sources

Anticardiolipin Antibodies in Scleroderma

JCR: Journal of Clinical Rheumatology, 2006
Raymond J, Enzenauer, David H, Collier, Luis R, Lopez   +2 more
openaire   +2 more sources

Anticardiolipin Antibodies and Prostacyclin Synthesis

Thrombosis and Haemostasis, 1987
VIOLI, Francesco, Valesini G, IULIANO, Luigi, Ghiselli A, FALCO, Mirella, Balsano F.   +5 more
openaire   +3 more sources

Anticardiolipin antibody

Arthritis & Rheumatism, 1987
openaire   +2 more sources